Latest News about Teva
Recent news which mentions Teva
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
From Benzinga
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
From Benzinga
3 Bargain Stocks to Buy on the Dip
June 17, 2023
From Motley Fool
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
From Benzinga
From Benzinga
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
From Motley Fool
Tickers
TEVA
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
From InvestorPlace
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?
May 18, 2023
From InvestorPlace
Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday
May 18, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tickers
TEVA
From Motley Fool
Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish
May 10, 2023
From Benzinga
From Benzinga
From Benzinga
Why this might be a good time to buy junk bonds
April 27, 2023
From MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
From Benzinga
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
April 15, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.